Method for silk fibroin gelation using sonication
This invention provides for a process of rapidly forming silk fibroin gelation through ultrasonication. Under the appropriate conditions, gelation can be controlled to occur within two hours after the ultrasonication treatment. Biological materials, including viable cells, or therapeutic agents can be encapsulated in the hydrogels formed from the process and be used as delivery vehicles.
1. A process of rapidly forming silk fibroin gelation, comprising exposing silk fibroin to a treatment comprising ultrasonication for a period of about 5 seconds to about 60 seconds to initiate gelation, wherein substantial silk fibroin gelation forms less than 24 hours after the ultrasonication treatment, and wherein the silk fibroin is in the form of an aqueous solution having a pH of 7.5 or higher.
2. The process of claim 1 , wherein the silk fibroin gelation forms less than two hours after the ultrasonication treatment.
3. The process of claim 1 , wherein the silk fibroin undergoes gelation at a time period ranging from about five minutes to about two hours after the ultrasonication treatment.
4. The process of claim 1 , wherein the treatment further comprises a salt solution.
5. The process of claim 4 , wherein the salt solution comprises ions selected from the group consisting of potassium, calcium, sodium, magnesium, copper, zinc, and combinations thereof.
6. The process of claim 5 , wherein the salt is potassium, the salt concentration is less than 100 mM.
7. A method of controlling gelation time of silk fibroin by contacting a silk fibroin solution with an ultrasonication treatment for period of about 5 seconds to about 60 seconds to initiate gelation, wherein the silk fibroin undergoes substantial gelation within about two hours, and wherein the silk fibroin solution has a pH of 7.5 or higher.
8. The method of claim 7 , wherein the silk fibroin undergoes gelation at a time period ranging from about five minutes to about two hours after the ultrasonication treatment.
9. The method of claim 7 , wherein the gelation time is controlled through the amplitude of the ultrasonication and the concentration of the silk fibroin solution.
10. The method of claim 7 , wherein the treatment further comprises a salt solution.
11. The method of claim 10 , wherein the gelation time is controlled through the concentration of the silk fibroin solution and the concentration of the salt solution.
12. The method of claim 11 , wherein the concentration of the silk fibroin is 4 wt % or lower, the salt solution comprises potassium ions, and the concentration of the potassium salt solution ranges from 20 mM to 100 mM.
13. The method of claim 10 , wherein the gelation time is controlled through the concentration and the pH of the salt solution.
14. The method of claim 13 , wherein the salt solution comprises potassium ions, the concentration of the potassium salt solution ranges from 20 mM to 100 mM.
15. A method of encapsulating at least one agent in silk fibroin, comprising:
a. contacting a silk fibroin solution with an ultrasonication treatment for a period of about 5 seconds to about 60 seconds to initiate gelation, wherein the silk fibroin solution has a pH of 7.5 or higher; and
b. introducing the agent(s) to the silk fibroin solution before substantial gelation occurs in the silk fibroin solution;
c. to form a silk-fibroin encapsulated agent.
16. The method of claim 15 , wherein the agent is a therapeutic agent or a biological material, or both.
17. The method of claim 16 , wherein the agent is at least one biological material selected from the group consisting of cells, proteins, peptides, nucleic acids, PNA, aptamers, antibodies, hormones, growth factors, cytokines, enzymes, antimicrobial compounds, and combinations thereof.
18. The method of claim 17 , wherein said cell is a stem cell.
19. The method of claim 17 , wherein a cell growth medium is introduced into silk fibroin with the biological material.
20. The method of claim 16 , wherein the agent is a therapeutic agent selected from the group consisting of small molecules, drugs, and combinations thereof.
21. The method of claim 15 , wherein the silk-fibroin encapsulated biological material is suitable for a biodelivery device.
22. The method of claim 15 , wherein substantial gelation occurs within about 2 hours.
23. The method of claim 15 , wherein substantial gelation occurs in the time period ranging from about five minutes to about two hours.
24. The process of claim 15 , wherein the treatment further comprises a salt solution.
25. A method of encapsulating at least one agent in silk fibroin, comprising:
a. introducing the agent(s) to a silk fibroin solution, wherein the silk fibroin solution has a pH of 7.5 or higher; and
b. contacting a silk fibroin solution with an ultrasonication treatment for a period of about 5 seconds to about 60 seconds to initiate gelation;
c. to form a silk-fibroin encapsulated agent.
26. The method of claim 25 , wherein the agent is a therapeutic agent selected from the group consisting of small molecules, drugs, and combinations thereof.
27. The method of claim 25 , wherein substantial gelation occurs within about two hours.
28. The method of claim 25 , wherein substantial gelation occurs in the time period ranging from about five minutes to about two hours.
29. The method of claim 25 , wherein power of ultrasonic waves is 3 watts to 21 watts.
30. The method of claim 15 , wherein power of ultrasonic waves is 3 watts to 21 watts.
31. The method of claim 7 , wherein power of ultrasonic waves is 3 watts to 21 watts.
32. The method of claim 1 , wherein power of ultrasonic waves is 3 watts to 21 watts.